ISHARES NASDAQ BIOTECHNOLOGY: (NASD: IBB)
$181.54
1.78 (0.99%)
Volume 590,983
May 21 04:00 PM ET
| Previous Close | 179.76 |
| Open | 180.10 |
| Bid | 180.83 |
| Ask | 181.76 |
| Day Low-High | 179.36-182.20 |
| 52wk Low-High | 118.29-186.98 |
| Avg Volume | 590,983 |
| NAV | NA |
| Expense Ratio | 0.48% |
| Dividend (Yield) | $0.63 (0.35%) |
| Issuer | BLACKROCK |
| IBB External Home Page >> | |
BENCHMARK for IBB
NASDAQ BIOTECHNOLOGY
The NASDAQ Biotechnology Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals which also meet other eligibility criteria determined by the Funds Index Provider, NASDAQ OMX Group, Inc., including minimum market capitalization and liquidity requirements.
FUND SUMMARY FOR IBB
ISHARES NASDAQ BIOTECHNOLOGY
The iShares Nasdaq Biotechnology Index Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index
Zacks ETF Rank : IBB
Zacks Premium Research
ETF Research Report
NYSE data is at least 20 minutes delayed.
NASDAQ data is at least 15 minutes delayed.
Zacks Commentary For IBB
Zacks Bull of the Day: Bull of the Day: Santarus (SNTS)
May, 22 2013
Zacks Blog: Biotechnology ETF Investing 101
May, 20 2013
Zacks Blog: Is the Biotech Sector Still a Market Leader?
Apr, 25 2013
Zacks Blog: Gilead Puts Biotech ETFs in Focus
Mar, 11 2013
News For IBB
Progenics Pharmaceuticals Added to the NASDAQ Biotechnology Index - Globenewswire
May 17, 2013
Hyperion Therapeutics Added to NASDAQ Biotechnology Index (NBI) - Globenewswire
May 16, 2013
NewLink Genetics to Be Added to NASDAQ Biotechnology Index - Marketwire
May 16, 2013
Synergy Pharmaceuticals Added to NASDAQ Biotechnology Index - Globenewswire
May 14, 2013
